Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis

AIMS: Long‐term treatment effect studies in large female Fabry patient groups are challenging to design because of phenotype heterogeneity and lack of appropriate comparison groups, and have not been reported. We compared long‐term cardiomyopathy and kidney function outcomes after agalsidase beta tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Wanner, Christoph, Feldt‐Rasmussen, Ulla, Jovanovic, Ana, Linhart, Aleš, Yang, Meng, Ponce, Elvira, Brand, Eva, Germain, Dominique P., Hughes, Derralynn A., Jefferies, John L., Martins, Ana Maria, Nowak, Albina, Vujkovac, Bojan, Weidemann, Frank, West, Michael L., Ortiz, Alberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261571/
https://ncbi.nlm.nih.gov/pubmed/32100468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12647
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi